The Journal of Medical Microbiology, Vol 35, Issue 1 40-44, Copyright © 1991 by Society for General Microbiology

JOURNAL ARTICLE

Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A

J. F. Torres
Department of Medical Microbiology, Gothenburg University, Sweden.

Most toxigenic strains of Clostridium difficile produce both toxin A and toxin B. The toxin produced by C. difficile strain 8864 was characterised and compared with those produced by C. difficile strain 10463. Toxin A was not detected by immunoassay in cultures from strain 8864 and all the cytotoxic activity produced by this strain was neutralised by antiserum to toxin B. Toxin B from strain 8864 was purified and compared with toxin B from strain 10463. The size of the purified subunits of toxin B from strain 8864 differed slightly from those of strain 10463 and there were small immunological differences. The effect on fibroblast cells was more like that of C. sordellii cytotoxin than of toxin B from strain 10463. These results suggest that C. difficile strain 8864 produces a modified toxin B and does not produce toxin A.

This article has been cited by other articles:

				T. Giesemann, M. Egerer, T. Jank, and K. Aktories Processing of Clostridium difficile toxins J. Med. Microbiol., June 1, 2008; 57(6): 690 - 696. [Abstract] [Full Text] [PDF]

				T. Jank, T. Giesemann, and K. Aktories Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function Glycobiology, April 1, 2007; 17(4): 15R - 22R. [Abstract] [Full Text] [PDF]

				D. E. Voth and J. D. Ballard Clostridium difficile Toxins: Mechanism of Action and Role in Disease Clin. Microbiol. Rev., April 1, 2005; 18(2): 247 - 263. [Abstract] [Full Text] [PDF]

				S. Johnson, S. P. Sambol, J. S. Brazier, M. Delmee, V. Avesani, M. M. Merrigan, and D. N. Gerding International Typing Study of Toxin A-Negative, Toxin B-Positive Clostridium difficile Variants J. Clin. Microbiol., April 1, 2003; 41(4): 1543 - 1547. [Abstract] [Full Text] [PDF]

				T. D. Wilkins and D. M. Lyerly Clostridium difficile Testing: after 20 Years, Still Challenging J. Clin. Microbiol., February 1, 2003; 41(2): 531 - 534. [Full Text] [PDF]

				P. Spigaglia and P. Mastrantonio Molecular Analysis of the Pathogenicity Locus and Polymorphism in the Putative Negative Regulator of Toxin Production (TcdC) among Clostridium difficile Clinical Isolates J. Clin. Microbiol., September 1, 2002; 40(9): 3470 - 3475. [Abstract] [Full Text] [PDF]

				C. Guilbault, A.-C. Labbe, L. Poirier, L. Busque, C. Beliveau, and M. Laverdiere Development and Evaluation of a PCR Method for Detection of the Clostridium difficile Toxin B Gene in Stool Specimens J. Clin. Microbiol., June 1, 2002; 40(6): 2288 - 2290. [Abstract] [Full Text] [PDF]

				G. Ackermann, Y. J. Tang, R. Kueper, P. Heisig, A. C. Rodloff, J. Silva Jr., and S. H. Cohen Resistance to Moxifloxacin in Toxigenic Clostridium difficile Isolates Is Associated with Mutations in gyrA Antimicrob. Agents Chemother., August 1, 2001; 45(8): 2348 - 2353. [Abstract] [Full Text] [PDF]

				S. P. Sambol, M. M. Merrigan, D. Lyerly, D. N. Gerding, and S. Johnson Toxin Gene Analysis of a Variant Strain of Clostridium difficile That Causes Human Clinical Disease Infect. Immun., October 1, 2000; 68(10): 5480 - 5487. [Abstract] [Full Text] [PDF]

				F. Hofmann, C. Busch, and K. Aktories Chimeric Clostridial Cytotoxins: Identification of the N-Terminal Region Involved in Protein Substrate Recognition Infect. Immun., March 1, 1998; 66(3): 1076 - 1081. [Abstract] [Full Text] [PDF]

				D. Lyerly, L. Neville, D. Evans, J Fill, S Allen, W Greene, R Sautter, P Hnatuck, D. Torpey, and R Schwalbe Multicenter evaluation of the Clostridium difficile TOX A/B TEST [In Process Citation] J. Clin. Microbiol., January 1, 1998; 36(1): 184 - 190. [Abstract] [Full Text]